Astromech

Ben Lamm

Colossal Spinout Astromech Acquires Sister Company Form Bio for $230M

by | Nov 17, 2026
The all-stock deal brings together two Dallas companies, pairing Astromech’s evolutionary AI models with Form Bio’s tools for designing genetic medicines. Form Bio co-founder Andrew Busey becomes Astromech’s chief AI officer.
MORE►
Ben Lamm
Astromech Raises $20M for Next Phase of Bringing AI to Evolutionary Biology
by | Aug 20, 2026
The Dallas-based Colossal Biosciences spinout, now valued at $3.8 billion, is preparing forecasting pilots in health and biosecurity as it scales the model behind its predictions.
MORE►
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►